A Phase ll, Randomized, Double-Blind, Placebo Controlled Bronchoscopy Study to Evaluate The Effects Of Lebrikizumab on Airway Eosinophilic Inflamation in Patients With Uncontrolled Asthma On Inhaled Corticosteroids and a Second Controller Medication

Project: Other project

StatusFinished
Effective start/end date5/28/145/15/18

Funding

  • Genentech, Inc.: $84,941.09